Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Telix Pharmaceuticals Limited
< Previous
1
2
Next >
Illuccix Approved in U.S. for Patient Selection for Pre-Taxane RLT
June 23, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
TLX
Telix Precision Medicine Announces AlFluor Radiochemistry Platform
June 20, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
TLX
Telix Theranostic Programs and Satellite Symposia on Innovation in PSMA and CAIX Imaging Featured at SNMMI 2025
June 19, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
TLX
Telix Launches New Prostate Cancer Imaging Agent, Gozellix, in U.S.
June 11, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
TLX
Telix Investor Day in New York City on June 11, 2025: Presenting KOLs
June 03, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
TLX
Telix to Host Investor Day in New York City on June 11, 2025
May 22, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
TLX
Telix FAP-targeting Therapeutic Published in Thyroid Journal: Demonstrates Encouraging Efficacy
May 07, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
TLX
Telix's Illuccix PSMA-PET Imaging Agent Approved in France
April 28, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
TLX
Telix Reports US$186M Q1 Revenue, Up 62% YOY
April 22, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
TLX
IPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma Therapy Candidate
April 15, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
TLX
Telix Announces Cardinal Health for Gozellix Commercial Distribution
April 08, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
CAH
TLX
Telix Appoints Paul Schaffer as Chief Technology Officer
April 07, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
TLX
Anne Whitaker Appointed as Non-Executive Director
April 03, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
ICLR
TLX
Telix Announces First Patient Dosed in First-in-Human ZOLAR Trial of TLX300-CDx in Advanced Soft Tissue Sarcoma
April 01, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
TLX
FDA Approves New Prostate Cancer Imaging Agent Gozellix®
March 21, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
TLX
Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin America
March 17, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
TLX
Telix Adds Lead-212 Isotope Production Capability
March 12, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
TLX
Investor Webinar: Telix Therapeutics Urology Showcase and Expert Forum
March 03, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
TLX
FDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review
February 25, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
TLX
Recruitment Spotlight: Phase 3 Clinical Trial of Novel Prostate Cancer Radiopharmaceutical Now Active in Miami
February 25, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
TLX
Telix 2024 Full Year Results: Record Financial Performance and Investment in Future Growth, FY2025 Guidance of up to $1.23 Billion
February 20, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
TLX
Telix to Showcase Urology Pipeline at Upcoming ASCO Genitourinary Cancers Symposium (ASCO GU 2025)
February 13, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
TLX
Illuccix® Approved in the United Kingdom
February 12, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
TLX
Telix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
January 30, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
TLX
Telix Completes Acquisition of RLS (USA) Inc.
January 27, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
TLX
Illuccix® Receives European Approval
January 16, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
TLX
Telix Presentation to the 43rd Annual J.P. Morgan Healthcare Conference
January 13, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
TLX
Telix Exceeds FY24 Guidance with US$142M Q4 Revenue
January 13, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
TLX
Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
January 12, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
TLX
NOBLE Registry Update: TLX599-CDx PSMA SPECT Imaging of Prostate Cancer Published in EJNMMI Reports
December 30, 2024
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
Tickers
ASX:TLX
TLX
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.